Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Recurso digital |
| Kieli: | englanti |
| Julkaistu: |
Zenodo
2025
|
| Linkit: | https://doi.org/10.5281/zenodo.17747867 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Sisällysluettelo:
- <p><span>The present<span> </span>study<span> </span>is<span> </span>investigated<span> for </span>formulation<span> </span>development<span> </span>and<span> </span>evaluation<span> </span>of<span> </span>Vitamin D<sub>3</sub>.<span> </span>Research<span> </span>is<span> </span>focused<span> </span>to<span> </span>improve<span> </span>the<span> </span>stability<span> </span>of<span> </span>the<span> </span>drug<span> </span>by<span> </span>changing<span> </span>the<span> </span>production process meant for the treatment of rickets, familial hypophosphatemia and hypoparathyroidism,<span> </span>and<span> </span>in<span> </span>the<span> </span>management<span> </span>of<span> </span><a name="_Hlk211117902"></a>hypocalcemia<span> </span>and<span> </span>renal<span> </span>osteodystrophy in patients with chronic renal failure undergoing dialysis, calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.</span></p>